Product Program year 2024 Source: CMS Open Payments

Opana

Drug Pain

NDC 63481-812-20

Open in the dashboard

General payments

$6,266

6 payments

Research payments

$242,118

112 payments

Through program year 2024, $6,266 in general payments and $242,118 in research payments were reported against Opana (Pain).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 Research $18,209 12
2023 Research $110,331 29
2022 Research $11,439 14
2021 General $6,171 5
2021 Research $39,248 15
2020 Research $56,791 28
2019 General $95 1
2019 Research $6,100 14

Breakdown

Who paid General payments · program years 2019–2021
  1. Endo Pharmaceuticals Inc. $6,266 6 payments
Top recipients General payments · program year 2021
  1. Richard Rauck Pain Medicine · Winston Salem, NC $2,160 35% · 2 payments
  2. William Zempsky Pediatrics · Hartford, CT $2,070 34% · 1 payment
  3. Johannes Van Den Anker Neonatal-Perinatal Medicine · Washington, DC $1,940 31% · 2 payments

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021
  1. Pain Medicine $2,160 35% · 1 practitioner
  2. Pediatrics $2,070 34% · 1 practitioner
  3. Neonatal-Perinatal Medicine Pediatrics $1,940 31% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. North Carolina $2,160 35% · 1 recipient
  2. Connecticut $2,070 34% · 1 recipient
  3. District of Columbia $1,940 31% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

6 general · 112 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record